Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery

被引：0
|
作者：
Dai, Cong [1 ]
Huang, Yu-hong [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, 92 Beier Rd, Shenyang 110001, Liaoning, Peoples R China
来源：
DIGESTIVE DISEASES AND SCIENCES | 2022年 / 67卷 / 04期
关键词：
Crohn's disease; Anti-TNF agents; Elective surgery; Complications; POSTOPERATIVE COMPLICATIONS; THERAPY;
D O I：
10.1007/s10620-021-06976-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1421 / 1422
页数：2
相关论文
共 50 条
  • [31] Optimizing Immunomodulators and Anti-TNF Agents in the Therapy of Crohn Disease
    Dassopoulos, Themistocles
    Sninsky, Charles A.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (02) : 393 - +
  • [32] Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease
    Larsen, Michael Due
    Qvist, Niels
    Nielsen, Jan
    Kjeldsen, Jens
    Nielsen, Rasmus Gaardskaer
    Norgard, Bente Mertz
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (06): : 650 - 656
  • [33] Anti-TNFα treatment efficacy in prevention of postoperative recurrence in Crohn's disease depends on previous exposure to anti-TNFα agents
    Collins, M.
    Sarter, H.
    Gower-Rousseau, C.
    Koriche, D.
    Nachury, M.
    Libier, L.
    Cortot, A.
    Zerbib, P.
    Colombel, J. -F.
    Peyrin-Biroulet, L.
    Desreumaux, P.
    de Chambrun, G. Pineton
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S316 - S316
  • [34] Rates of Anti-TNF Drug Persistence in Patients with Crohn's Disease
    Alexa, Silfen
    Tina, Rodriguez
    Jordan, Karpin
    Cindy, Traboulsi
    Victoria, Rai
    David, Rubin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S9 - S9
  • [35] Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease
    D'Amico, Ferdinando
    Pugliese, Nicola
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 347 - 353
  • [36] Anti-TNFα Treatment Efficacy in Prevention of Postoperative Recurrence in Crohn's Disease Depends on Previous Exposure to Anti-TNFα Agents
    Collins, Michael
    Sarter, Helene
    Gower-Rousseau, Corinne
    Koriche, Dine
    Nachury, Maria
    Libier, Louise
    Cortot, Antoine
    Zerbib, Philippe
    Colombel, Jean-Frederic
    Peyrin-Biroulet, Laurent
    Desreumaux, Pierre
    de Chambrun, Guillaume Pineton
    GASTROENTEROLOGY, 2015, 148 (04) : S863 - S863
  • [37] Comparative Effectiveness and Safety of Anti-TNF Agents for Crohn's Disease in Biologic-Naive Patients
    Singh, Siddharth
    Sangaralingham, Lindsey R.
    Heien, Herbert
    Anderson, Stephanie S.
    Shah, Nilay
    Loftus, Edward V.
    GASTROENTEROLOGY, 2015, 148 (04) : S175 - S175
  • [38] Efficacy of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF
    Mozziconacci, Nicolas
    Vermeire, Severine
    Laharie, David
    Louis, Edouard
    Bigard, Marc-Andre
    Hebuterne, Xavier
    Bouhnik, Yotam
    Van Assche, Gert A.
    Lemann, Marc
    Rutgeerts, Paul J.
    Colombel, Jean-Frederic
    Allez, Matthieu
    GASTROENTEROLOGY, 2008, 134 (04) : A663 - A663
  • [39] To Stop or Not to Stop? Predicting Relapse After Anti-TNF Cessation in Patients With Crohn's Disease
    Christopher, M. A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1668 - 1670
  • [40] Anti-TNF antibody treatment of Crohn's disease
    van Deventer, SJH
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 114 - 120
12345